U.S. Health Secretary Robert F. Kennedy Jr. Advocates Deprescribing of Psychiatric Medications

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is intensifying his campaign to encourage Americans to stop using psychiatric drugs, a strategy known as deprescribing.

The effort, reported by STAT, follows earlier statements this month in which Kennedy highlighted concerns about widespread antidepressant use.

While the push is framed as a public‑health initiative, it adds to ongoing debates about the safety and necessity of long‑term psychiatric medication use.

The article also notes other industry news, including a Sanofi blood‑cancer drug and China’s out‑licensing deals, but the primary focus remains on Kennedy’s deprescribing agenda.